Updates in Regulatory Guidelines for Blood Pressure Monitoring in Clinical Trials Webinar Replay
As regulatory bodies increase demands on drug manufacturers to study pressor effects of medications, it’s important to understand ABPM monitoring as a safety measure for chronic drug intake. But monitoring blood pressure effects in clinical trials can be challenging not only to the patient but to the sponsor as well.
Come watch our panel of cardiologists in this replay, “Updates in Regulatory Guidelines to Blood Pressure Monitoring in Clinical Trials”, where you can gain insights on the new draft guidance, and how to reduce data variability and increase patient compliance in blood pressure monitoring. The discussion is held by experts Robert Kleiman, MD, Vice President, Cardiology and Chief Medical Officer, Todd Rudo, MD, Deputy Chief Medical Officer, Cardiac Safety, Jeff Heilbraun, MS, Medical and Scientific Affairs, and moderated by Borje Darpo, MD, PhD, Chief Scientific Advisor of Cardiac Safety.
Featured Topics:
- Scientific background
- Interpreting the updates to the FDA guidance
- Practical considerations
- Audience Q&A
